ChemicalBook >> CAS DataBase List >>Foretinib (GSK1363089)

Foretinib (GSK1363089)

CAS No.
849217-64-7
Chemical Name:
Foretinib (GSK1363089)
Synonyms
Foretinib;XL880;EXEL-2880;GSK089;GSK 1363089;XL-880,Foretinib;EXEL-2880/XL-880;Foretinib, >=98%;XL880(GSK1363089);Foretinib (XL-880)
CBNumber:
CB02490083
Molecular Formula:
C34H34F2N4O6
Molecular Weight:
632.65
MDL Number:
MFCD22379992
MOL File:
849217-64-7.mol
MSDS File:
SDS
Last updated:2023-06-08 09:02:17

Foretinib (GSK1363089) Properties

Melting point >98°C (dec.)
Boiling point 828.5±65.0 °C(Predicted)
Density 1.372
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility DMSO (Slightly), Ethanol (Slightly)
form Yellow powder.
pka 13.14±0.70(Predicted)
color Pale Yellow to Yellow
CAS DataBase Reference 849217-64-7
NCI Dictionary of Cancer Terms foretinib; XL880
FDA UNII 81FH7VK1C4
NCI Drug Dictionary foretinib

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS08,GHS07
Signal word  Warning
Hazard statements  H373-H302
Precautionary statements  P260-P314-P501-P264-P270-P301+P312-P330-P501
NFPA 704
0
2 0

Foretinib (GSK1363089) price More Price(40)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 16249 Foretinib ≥98% 849217-64-7 1mg $32 2024-03-01 Buy
Cayman Chemical 16249 Foretinib ≥98% 849217-64-7 5mg $86 2024-03-01 Buy
Cayman Chemical 16249 Foretinib ≥98% 849217-64-7 10mg $109 2024-03-01 Buy
Cayman Chemical 16249 Foretinib ≥98% 849217-64-7 25mg $230 2024-03-01 Buy
Tocris 6056 GSK1363089 ≥98%(HPLC) 849217-64-7 10 $177 2021-12-16 Buy
Product number Packaging Price Buy
16249 1mg $32 Buy
16249 5mg $86 Buy
16249 10mg $109 Buy
16249 25mg $230 Buy
6056 10 $177 Buy

Foretinib (GSK1363089) Chemical Properties,Uses,Production

Description

Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM in cell-free assays. Less potent against Ron, Flt-1/3/4, Kit, PDGFRα/β and Tie-2, and little activity to FGFR1 and EGFR. Phase 2.

Description

Foretinib is a multikinase inhibitor that targets MET and VEGFR2 and also exhibits an inhibitory effect against KIT, Flt-3, PDGFRb, and Tie-2.

Uses

XL880 (GSK1363089, EXEL-2880) is an ATP-competitive inhibitor of MET and KDR with IC50 of 0.4 nM and 0.9 nM, respectively.

Uses

Foretinib (GSK1363089) is an ATP-competitive inhibitor of hepatocyte growth factor (HGF) and Vascular endothelial growth factor (VEGF) Receptor Tyrosine Kinases.

Definition

ChEBI: N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide is an aromatic ether.

Clinical Use

Foretinib has also shown to be effective against ROS1 mutations especially when acquired with crizotinib resistance. A clinical trial investigating the dosing and safety profile of combining foretinib and erlotinib was designed for advanced pretreated NSCLC patients.

in vitro

In vitro, foretinib blocks activation of MET and VEGFR2-induced signaling pathways. In vivo experiments show a dose-dependent decrease in tumor burden in a lung metastasis experimental model.

target

Met

References

[1] qian f1, engst s, yamaguchi k, yu p, won ka, mock l, lou t, tan j, li c, tam d, lougheed j, yakes fm, bentzien f, xu w, zaks t, wooster r,greshock j, joly ah. inhibition of tumor cell growth, invasion, and metastasis by exel-2880 (xl880, gsk1363089), a novel inhibitor of hgf and vegf receptor tyrosine kinases. cancer res. 2009 oct 15;69(20):8009-16. doi: 10.1158/0008-5472.can-08-4889.

Foretinib (GSK1363089) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 175)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Anqing Chico Pharmaceutical Co., Ltd.
15380796838 chloewu@chicopharm.cn CHINA 341 58
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Changzhou PBpharmaceutical R&D Co.,Ltd
0519-83990708 info@pbpharm.com CHINA 498 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58

View Lastest Price from Foretinib (GSK1363089) manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Foretinib (GSK1363089) pictures 2022-10-14 Foretinib (GSK1363089)
849217-64-7
US $0.00-0.00 / KG 1KG 98% 1Ton Henan Aochuang Chemical Co.,Ltd.
Foretinib (GSK1363089) pictures 2019-07-06 Foretinib (GSK1363089)
849217-64-7
US $2.00 / kg 1 kg 99% 100kg Career Henan Chemical Co

Foretinib (GSK1363089) Spectrum

849217-64-7(Foretinib (GSK1363089))Related Search:

GSK 1363089 N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide XL-880,Foretinib XL880(GSK1363089) FORETINIB GLAXOSMITHKLINE PAPILLARY RENAL CELL CARCINOMA PHASE IIRSCH. TRIANGLE PARK, NC (SEE ALSO HEAD/NECK) (888) 825-5249 foretinib N1-{3-fluoro-4-[(6-(Methyloxy)-7-{[3-(4-Morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}-N1'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide Foretinib (GSK1363089, XL880) GSK089 GSK1363089; FORETINIB; EXEL-2880 Foretinib, Free Base EXEL-2880/XL-880 N-(3-fluoro-4-(6-Methoxy-7-(3-Morpholinopropoxy)quinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide N1'-[3-fluoro-4-[[6-Methoxy-7-(3-Morpholinopropoxy)-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide GSK1363089/foretinib N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl)cyc Foretinib (GSK1363089) N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1 Foretinib, >=98% Foretinib (XL-880) N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl) 1-N'-[3-FLUORO-4-({6-METHOXY-7-[3-(MORPHOLIN-4-YL)PROPOXY]QUINOLIN-4-YL}OXY)PHENYL]-1-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE Foretinib (XL880,EXEL-2880) XL880 (GSK1363089, Foretinib, EXEL-2880) XL-880;EXEL-2880;XL 880 XL-880;GSK089;EXEL-2880;XL 880;GSK-089; GSK 1363089; GSK-1363089 XL880; XL 880; XL-880; GSK1363089; GSK 1363089; GSK-1363089; GSK089; EXEL2880; FORETINIB. 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)- Foretinib (GSK1363089) USP/EP/BP N1'-[3-fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)-4-quinol... Foretinib EXEL-2880 XL880 849217-64-7 C34H34F2N4O6 Inhibitors